Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genefic (formerly Dalrada Health) is a wholly-owned subsidiary of Dalrada Financial Corporation that operates a specialty pharmacy business. The subsidiary accounts for nearly 80% of Q3 2024 revenue ($10.3 million total company revenue) and has expanded into the $42 billion infusion pharmacy marketplace through acquisition of IV Services Infusion Pharmacy, and entered the $6 billion weight loss drug market through new telemedicine services
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalrada Health.